Local Institution

Lexington, Kentucky 40536

0 studies enrolling now · 14 studies all time

What they study most

Bipolar Disorder, Chronic Myeloid Leukemia, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Diabetes, Type 2, Kawasaki Disease, Leukemia, Lymphocytic, Acute, L2, Leukemia, Myeloid, Chronic, Lymphoma, Major Depressive Disorder, Metabolics Diabetes Nos, Multiple Myeloma

Studies at this site

• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• Aripiprazole in Adolescents With Schizophrenia — Completed
• Aripiprazole in Children and Adolescents With Bipolar I Disorder — Completed
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• PPAR-COMBO With Sulfonylurea — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed
• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed